logo-loader
viewAdmedus Ltd

Admedus appoints new company secretary and general counsel

New executive brings 20 years of relevant experience to the company.

Boardroom
The company’s medical technologies deliver life-changing outcomes

Admedus Ltd (ASX:AHZ) has appointed Tanya Mangold as company secretary and general counsel.

She will be based in Brisbane and replaces Maja McGuire in the roles.

The new executive brings to the role circa 20 years of relevant experience, gained in South Africa and Australia.

This has included working with listed companies as a general counsel, company secretary and in top-tier private practice.

WATCH NOW: Admedus Ltd moving up the value chain and preparing for 'pivotal' year

Admedus, a medical technologies company, increased 10% mid-afternoon to $0.275.

Mangold has postgraduate taxation qualifications, was admitted as a solicitor in Australia in 2008, and is a member of the Queensland Law Society and Australian Institute of Company Directors.

Admedus delivers solutions that help healthcare professionals create life-changing outcomes for patients.

Next generation technologies

The company’s focus is on investing in and developing next-generation technologies with world-class partners as well as acquiring strategic assets to grow product and service offerings.

It also aims to expand revenues from its existing medical sales and distribution business. Admedus has assets from research and development through clinical development as well as sales, marketing and distribution.

READ: Admedus introduces heart tissue technology to India

The company recently introduced its ADAPT® engineered tissue technology to India, a country with circa 50 million cardiac patients and 280,000 babies born annually with a Congenital Heart Defect.

Physicians in India now have access to the benefits of the disruptive ADAPT technology and Admedus’ flagship product CardioCel® to provide life-changing outcomes for patients.

Quick facts: Admedus Ltd

Price: 0.0865 AUD

ASX:AHZ
Market: ASX
Market Cap: $51.11 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Admedus Ltd named herein, including the promotion by the Company of Admedus Ltd in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Admedus CEO in New York to update on recent key milestones

Admedus Ltd (ASX:AHZ) CEO Wayne Paterson visited the Proactive Investors New York studio to update on key milestones the company has achieved in the past few months, including receiving European approval on two of its products.

on 03/17/2019

2 min read